-
Recent Posts
- Evidence on the Potential of the Arts for Improving Mental and Physical Health and Wellbeing (WHO)
- Demand for Mental Health Inpatient Beds in England (BBC News / NHS Strategy Unit)
- Dementia Services in England: Mega Statistical Package (PHE / NMHDNIN)
- Mandatory Learning Disability and Autism Awareness Training for NHS Staff (DHSC / BBC News)
- Detention of Children and Young People With Learning Disabilities and/or Autism (Joint Committee on Human Rights / BBC News)
Archives
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Alistair Burns: Professor of Old Age Psychiatry at University of Manchester
Support Workers for General Practice: Part of the NHS Comprehensive Personalised Care Model (BBC News / NHS England)
Summary Over 20,000 physiotherapists, pharmacists, paramedics, physician associates, and social prescribing support workers will be recruited by NHS England to work with general practices. The aim is to help relieve workload pressures on GPs. Full Text Link Reference GPs create … Continue reading →
Posted in BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, National, NHS, NHS England, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest
|
Tagged Ageing Population, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Avoidable Hospital Admissions, BBC Health News, BMA General Practitioners Committee (GPC), Clinical Pharmacists, Directed Enhanced Service (DES), Dr Keith Ridge: Chief Pharmaceutical Officer, Expanded Services at Local GP Practices, Five-Year GP Services Contract, GP Contract Five-Year Framework, GP Contract Reform to Implement the NHS Long Term Plan: NHS England, Improving Access to Family Doctors, Integrated Care Systems, Integrated Care Systems (ICSs), Integrated Personal Budgets (IHBs), Longer Appointments for Complex Patients, Medication Reviews, NHS Comprehensive Personalised Care Model, NHS Long Term Plan (2019), NHS Long Term Plan: GP Services, NHS Long Term Plan: Implementation, Over-Medication, Paramedics, Patient Activation, People Powered Health and Supported Self-Management, Personal Health Budgets (PHBs), Personalised Care and Support Planning (PCSP), Pharmacists, Pharmacists to Cut Unnecessary Hospital Admissions, Pharmacy Reviews, Pharmacy Technicians, Physician Associates, Physiotherapists, Preventable Hospital Admissions, Primary Care Network (PCN) Contract, Primary Care Network Model, Primary Care Networks, Quality and Outcomes Framework (QOF), Quality and Outcomes Framework (QOF): Blood Pressure Control, Quality and Outcomes Framework (QOF): Diabetes, Quality and Outcomes Framework (QOF): End of Life Care, Quality and Outcomes Framework (QOF): Prescribing Safety, Reducing Delayed Transfers of Care, Reducing Over-Medication (NHS England), Reducing Re-Admissions to NHS Hospitals, Reducing Unnecessary Admissions, Reducing Unnecessary Medication (NHS England)), Reducing Unnecessary Transitions, Reducing Unnecessary Trips to Hospital, Reducing Unplanned Hospital Admissions, Reducing Unscheduled Admissions, Social Prescriber Link Workers, Social Prescribing, Social Prescribing Support Workers, Social Prescribing: Link Workers, Tackling Over-Medication, Technology to Support Personalised Health and Care, Technology-Supported Self-Management, Universal Personalised Care: Implementing the Comprehensive Model
|
Leave a comment
Historic Reduction in the Use of Antipsychotics for BPSD in UK General Practice? (Drug Safety)
Summary Data from 111,346 patients with dementia but without a concomitant diagnosis of psychosis indicates that prescribing of certain categories of antipsychotic drugs did reduce from 8.9% in 2001 to 1.4% in 2014. At face value, this reduction in inappropriate … Continue reading →
Posted in Antipsychotics, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, NICE Guidelines, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK
|
Tagged Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Amisulpride, Antipsychotic Drugs, Antipsychotic Prescribing in Primary Care, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Centre for Health Informatics: University of Manchester, Centre for Pharmacoepidemiology and Drug Safety: University of Manchester, Centre for Primary Care (University of Manchester), Clinical Practice Research Datalink (CPRD), Discontinuation of Antipsychotics, Division of Informatics Imaging and Data Sciences: University of Manchester, Division of Neuroscience and Experimental Psychology: University of Manchester, Division of Pharmacy and Optometry: University of Manchester, Division of Population Health Health Services Research and Primary Care: University of Manchester, Division of Primary Care: University of Manchester, Division of Psychology and Mental Health: University of Manchester, Drug Safety (Journal), English National Dementia Strategy, First-Generation Antipsychotic Drugs, General Practice, Inappropriate Use of Antipsychotics in Dementia, Longitudinal Changes in Inappropriate Prescribing, Manchester, Manchester Academic Health Sciences Centre, MHRA Committee for the Safety of Medicines, National Dementia Challenge, National Dementia Strategy, National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre: University of Manchester, Neuroleptic Discontinuation, Neuroleptics, Olanzapine, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Prime Minister’s Dementia Challenge, Professor Alistair Burns, Psychological Symptoms of Dementia (BPSD), Queen's Medical Centre: University of Nottingham, Quetiapine, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Risperidone, School of Biological Sciences: University of Manchester, School of Health Sciences: University of Manchester, School of Medicine: University of Nottingham, Second-Generation Antipsychotic Drugs, Temporal Changes in Prescribing of Antipsychotic Drugs from 2001 to 2014, University of Manchester, University of Nottingham, Use of Antipsychotics for BPSD in UK General Practice
|
Leave a comment
Developments in Dementia Research: From the Horses’ Mouths (NHS England / NIHR)
Summary Professor Alistair Burns (NHS England’s National Clinical Director for Dementia and Older Peoples’ Mental Health), and Professor Martin Rossor (NIHR National Director for Dementia Research), discuss current issues and new approaches in dementia research, touching briefly upon some of … Continue reading →
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, National, NHS England, NIHR, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged 100000 Genomes Project, A4 Study, Alistair Burns: Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT), Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alzheimer's Prevention Initiative, Alzheimer’s Disease Biomarkers, Alzheimer’s Prevention Initiative Study, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study), APP and Presenilin, Asymptomatic Alzheimer’s Disease, Banner Alzheimer's Institute, Biomarkers, Chance Genetic Mutations, Colombia, Colombian Alzheimer's Prevention Initiative Registry in Medellín Antioquia, DIAN-TU Study, DIAN-TU Trial, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, Genentech, Genomics, Genomics England, Genomics in the NHS, Genomics-Based Medicine, Global Outlook, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Medellin (Colombia), Monoclonal Antibodies, MRC Neurochemical Pharmacology Unit, Mutational Signatures, National Clinical Director for Dementia, National Institute for Health Research (NIHR), National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, NIHR Clinical Research Network, NIHR Dementia Translational Research Collaboration, NIHR National Director for Dementia Research, NIHR Translational Research Collaboration, Overcoming Barriers, Participation in Research, Participation in Research Studies, Preclinical Alzheimer's Disease, Presenilin, Prodromal Alzheimer's Disease, Professor Alistair Burns, Professor Martin Rossor: Director of the NIHR Queen Square Dementia Biomedical Research Unit, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: Former President of the Association of British Neurologists (2011-2013), Professor Martin Rossor: Honorary Consultant Neurologist at National Hospital for Neurology and Neurosurgery, Professor Martin Rossor: National Hospital (Queen Square), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Promisary Science, Reducing Downstream Effects of Disease, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Research Promotion, Sharing Knowledge and Information, Slowing Progression of Disease (Stabilisation), Solanezumab (Sola or Solab), Solanezumab: Humanised Monoclonal Antibody, Therapeutic Nihilism (Avoiding), Translational Research, UK Genomes Project: Genomics England, University of Southern California’s Alzheimer’s Therapeutic Research Institute, Washington University School of Medicine
|
Leave a comment
Timely Reflections on Dementia Awareness (NHS England / UKMi)
Summary Professor Alistair Burns, NHS England’s National Clinical Director for Dementia, marks National Dementia Awareness Week. Full Text Link Reference Great strides are being made in dementia awareness – Professor Alistair Burns. London: NHS England, May 20th 2016. Further elaboration, … Continue reading →
Posted in Alzheimer's Society, Diagnosis, For Carers (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged Ageing and Dementia, Ageing and Society, Alistair Burns, Alistair Burns: Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT), Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Awareness and Understanding, Awareness Campaigns, Barriers to Early Diagnosis, Care Planning, Delays in Diagnosis of Dementia, Dementia Awareness Week, Dementia Awareness Week (2016), Dementia Diagnosis, Dementia Diagnosis and Care in England, Dementia Diagnosis Rates, Dementia Friends, Dementia Friends Programme, Dementia Research, Dementia Research Funding, Dementia-Friendly Communities, Diagnosis, Diagnosis and Assessment, Diagnosis of Dementia, Early Diagnosis, Living Well with Dementia, medeConnect, Myth-Busting, Myths and Misconceptions About Dementia, National Dementia Awareness Week, National Dementia Helpline, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Post-Diagnostic Support, Reasons For Delays in Diagnosis of Dementia, Reducing Stigma, Southampton Medicines Advice Service, Staying Healthy for Longer, Stigma-Free Environments, Thinking Ahead: Dementia Awareness Week (Theme Revamped For 2016), Timely Diagnosis, UK Medicines Information (UKMi), UKMi, YouGov Plc
|
Leave a comment
Focus on Dementia – January 2016 Statistical Update (HSCIC / Alzheimer’s Society)
Summary The Health and Social Care Information Centre (HSCIC) has published statistics on dementia. These statistics focus on five strategic aspects of dementia care: Prevention. Diagnosis. Post-Diagnostic Support. Living Well With Dementia. Mortality Associated With Dementia. It may be of … Continue reading →
Posted in Acute Hospitals, Alzheimer's Society, Commissioning, Community Care, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest
|
Tagged Adult Secondary Mental Health and Learning Disabilities Services: UK Statistics (HSCIC), Ageing Population, Alcohol Consumption in Middle Age: UK Statistics (HSCIC), Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alzheimer's Society’s Fix Dementia Care Campaign, Cardiovascular Risk Factors, Cardiovascular Risk Factors (CVRF), Cardiovascular Risk Factors Aging and Dementia Study, Care Clusters, Carer Experience: UK Statistics (HSCIC), Carer Wellbeing: UK Statistics (HSCIC), Dementia - Post-Diagnostic Support: UK Statistics, Dementia and Mortality, Dementia by Ethnic Origin: UK Statistics (HSCIC), Dementia by Gender: UK Statistics (HSCIC), Dementia Diagnosis Rates, Dementia Diagnosis: UK Statistics, Dementia Drugs Prescriptions: UK Statistics, Dementia Prevention: UK Statistics, Dementia Risk Factors, Dementia Survival Analysis: UK Statistics (HSCIC), Dementia-Related Care Clusters, Diabetes: UK Statistics (HSCIC), Donepezil and Memantine, Donepezil Hydrochloride, Fix Dementia Care Campaign, Fix Dementia Care: Hospitals, Fix Dementia Care: Hospitals (Alzheimer’s Society), Focus on Dementia Report: January 2016 (HSCIC), Galantamine, Health and Social Care Information Centre (HSCIC), Health Survey for England (HSE), High Blood Pressure: UK Statistics (HSCIC), HSCIC: Health and Social Care Information Centre, Improving Dementia Diagnosis Rates, Inconsistent Hospital Record-Keeping: Patients With Dementia, Later Life, Living Well After Diagnosis, Living Well with Dementia, Living Well With Dementia: UK Statistics, Median Survival Time After Dementia Diagnosis, Memantine, Mental Health and Learning Disabilities Statistics, Mental Health Care Clusters, Modifiable Risk Factors, Mortality Associated With Dementia: UK Statistics, Neurological Disorders, NHS Wellbeing Pathway, Obesity in Middle Age: UK Statistics (HSCIC), Office for National Statistics (ONS), ONS Mortality Data, Patient-Led Assessment of the Care Environment: UK Statistics (HSCIC), Patient-Led Assessments of the Care Environment (PLACE), Personal Social Services Survey of Adult Carers in England, Physical Inactivity in Middle Age: UK Statistics (HSCIC), Poor Diet in Middle Age: UK Statistics (HSCIC), Prescribing in Primary Care: UK Statistics (HSCIC), Prescriptions Dispensed in the Community, Prevalence of Dementia, Professor Alistair Burns, Progression of Dementia: UK Statistics (HSCIC), Public Health England Fingertips Tool, Quality Outcomes Framework (QOF): Recorded Dementia Diagnoses, Recording Inconsistencies: Hospital Inpatient Admissions, Risk Factors, Rivastigmine, Smoking in Middle Age: UK Statistics (HSCIC), Support for Carers, Wellbeing in an Ageing Population
|
Leave a comment
